作者: K.Y. Lee , S.Y. Jeon , J.W. Hong , K.W. Choi , C.Y. Lee
DOI: 10.1111/J.1468-3083.2012.04498.X
关键词:
摘要: Background Vitiligo is an acquired pigmentary disorder caused by the destruction of melanocytes. Two major theories regarding pathogenesis vitiligo are autoimmune theory and autocytotoxicity theory, but, precise pathogenetic mechanism still not clarified. Objectives We investigated effects ET-1, tacrolimus tumour necrosis factor-α (TNF-α) on proliferation migration cultured normal human melanocytes (NHMs). also sought to clarify theoretical rationale underlying topical monotherapy or tacrolimus-UV combination therapy as tools for treatment. Methods The TNF-α proliferation/migration NHMs were MTT assay/Boyden chamber transwell assay. examined roles CXC-chemokine receptor II (CXCR II) matrix metalloproteinases (MMPs) in such conditions. Results ET-1 exerted a stimulatory effect melanocyte migration, only higher than ET-1. inhibited dose-dependent manner. Paradoxically, TNF-α-pretreated exhibited enhanced proliferative efficiency after being switched found CXCRII was highly expressed TNF-α-incubated agents-free control, treatment preincubation showed levels expression condition incubated with alone. Moreover, greater activities MMP-2 MMP-9 induced reflected would enhance NHMs. Conclusions Topical can be used effective agent monotherapy, maybe due its action inhibitory property, component UV treatment, considering more upregulated MMPs migrations feasible itself